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Crystal structures of 3-methyl-2(1H)-
quinoxalinone and three substituted
derivatives
Denise Mondieiga*, Philippe Negriera, Ste´phane Massipb,
Jean Michel Legerb, Chakir Jarmoumic and Brahim Lakhrissic
3-Methyl-2(1H)-quinoxalinone and three derivatives (3,7-dimethyl-2(1H)-quinoxalinone, 3-methyl-6,7-dichloro-
2(1H)-quinoxalinone and 3-methyl-7-nitro-2(1H)-quinoxalinone) have been synthesised and analysed by 1H NMR 
and IR spectral spectroscopies. The crystal structures have been determined at room temperature from X-ray single
crystal diffraction data for three of them and from powder diffraction data for the nitro derivative. 3-Methyl-2(1H)
-quinoxalinone crystallises in the P21/c monoclinic system, 3,7-dimethyl-2(1H)-quinoxalinone in the Pbca orthor-
hombic system and the two others compounds in the P1 triclinic system. For the nitro derivative, C—H  N short 
contacts are established between the carbon of the methyl and the double bounded nitrogen of the ring. For the
three other compounds N—H  O hydrogen bonds involve the atoms of the heterocyclic ring.
Keywords: 3-methyl-2(1H)-quinoxalinone derivative; intermolecular interaction; powder structure; single crystal structure;
synthesis
INTRODUCTION
Quinoxalin-2-ones display interesting biological properties,
including the inhibition of the aldose reductase enzyme,[1]
partial agonists for complex receptors g-aminobutyric acid
(GABA)/benzodiazepine[2–4] and as multiple-drug-resistance
antagonists,[5] amongst others properties. Additionally, the
quinoxalin-2-one (Fig. 1) showed antimicrobial,[6–8] antifungic,[9]
antiviral[10] and anticancer[11] activities. Methylquinoxalin-2(1
H)-one had recently been identified as corrosion inhibitor for mild
steel in 1M HCl solution.[12] Hence it is of interest to obtain
accurate structural parameters of these molecules. Up today, only
few structural data on quinoxalin-2-one derivatives have been
published. Two papers[13,14] reported on the 2-hydroxyquinoxa-
line structure and another one on a different compound as
3-benzoylmethylene-1-methyl-3,4-dihydroquinoxalin-2(1H)-one[15]
or 2-[N-(2-hydroxyethyl) carboxamide]-3-methylquinoxaline
1,4-dioxide.[16]
In this article, we focus on the crystal structures of four
substituted 3-methyl-2(1H)-quinoxalinones which have been
synthesised and analysed by NMR and IR spectroscopies. The
structures of 3-methyl-2(1H)-quinoxalinone, 3,7-dimethyl-2(1H)-
quinoxalinone and 3-methyl-6,7-dichloro-2(1H)-quinoxalinone
were determined from single crystal data while the structure
of 3-methyl-7-nitro-2(1H)-quinoxalinone was obtained from
powder X-ray diffraction data.
EXPERIMENTAL PART
Synthesis of substituted 3-methyl-2(1H)-quinoxalinones 6–9
Substituted 3-methyl-2(1H)-quinoxalinones 6–9 were prepared
by the reaction of the corresponding o-phenylenediamines 1–4
and ethyl pyruvate 5 in aqueous HCl[17] (Scheme 1). The yields
of products 6–9 were in the range of 75–85%. Bakerman et al.
suggested a mechanism,[18] in which the two amino groups
of 1–4 stepwisely attack the two carbonyl centers of 5 (first to
the carbonyl carbon) followed by elimination of water and
ethanol.
General methods
All chemicals were purchased from Aldrich or Acros (France). All
solvents were distilled before use. Thin-layer chromatography
(TLC) was performed on Silica Gel 60 F254 (E. Merck) plates with
visualisation by UV light (254 nm). Melting points were evaluated
by means of a DSC7 Perkin Elmer. Because of the elevated
temperature of melting, we use a relatively high heating rate
10 Kmin1 in order to diminish the time of heating and thus to
prevent degradation of the material. 1H NMR spectra were
recorded on a Bruker 300 WB spectrometer at 300MHz, in
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Me2SO-d6. Chemical shifts are given as d values with reference to
tetramethylsilane (TMS) as internal standard. Infrared (IR) spectra
were performed on Bruker tensor 27 FT/IR spectrophotometer.
Synthesis of 3-methyl-2(1H)-quinoxalinone 6 and its
derivatives 7–9
A solution of 1 (5.4 g, 50mM) in aq. HCl (20%, 50mL) was added
to a solution of ethyl pyruvate (11.6 g, 100mM) in aq. HCl (20%,
50mL). The mixture was stirred at room temperature for 15min.
The dark coloured precipitate of 6 was filtered, washed with
water (2 20mL) and dried on anhydrous sodium sulphate to
give light-yellow crystals of 3-methyl-2(1H)-quinoxalinone 6
(6.0 g, yield 75%, mp 251 5 8C).
3,7-Dimethyl-2(1H)-quinoxalinone 7 (6.61 g, yield 76%, mp
217 5 8C), 3-methyl-7-nitro-2(1H)-quinoxalinone 8 (10.1 g, yield
88%, mp 250 5 8C), and 3-methyl-6,7-dichloro- 2(1H)- quinox-
alinone 9 (8.03 g, yield 85%, mp 336 5 8C) were prepared by
the procedure similar to that used in the preparation of 6. All
compounds were recrystallised from a mixture of DMF-ethanol
(v/v, 3:7). The 1H NMR and IR spectral data of 6–9 are shown in
Table 1.
X-ray diffraction measurements
For compounds 6 and 9 X-ray crystal measurements were
performed with an Enraf-Nonius CAD4 using the ‘Enraf-Nonius
SDP’ program system. The crystal of 7 has been measured with a
R-Axis Rapid diffractometer equipped with a rotating anode and
an image plate. The X-ray wavelength was Cu-Ka (l¼ 1.54180 A˚).
The structures were solved by direct methods and refined by
full-matrix least-squares using SHELXS-97 software. All of the
non-hydrogen atoms were refined anisotropically meanwhile the
H-atoms were allowed to ride on the parent atoms in the model.
Additional details of structure determination are summarised in
Table 2.
For 8, we did not obtain single crystals of quality good
enough for single crystal X-ray structure determination.
Consequently we performed high-quality powder X-ray diffrac-
tion measurements by an INEL CPS-120 diffractometer operating
with Debye–Scherrer transmission geometry. Powder diffraction
patterns were collected on a 1208 curved counter by gas ionisa-
tion (ArgonþC2H6). Powder sample was loaded into 0.5mm
diameter Lindemann glass capillary that is rotated about its
axis during data collection in order to minimise the crystallites
preferential orientation. The powder pattern was measured in a
2u range from 38 to 1068 (step size¼ 0.0298) although the
information used for structure determination ranges from 3.58 to
658. Pattern was recorded during six hours at room temperature.
Monochromatic Cu-Ka1 radiation (l¼ 1.5405 A˚) was selected
with asymmetric focusing incident-beam curved quartz
Figure 1. Substituted quinoxalin 2 ones
Scheme 1.
Table 1. Spectral data of 2(1H)-quinoxalinones derivatives
Product 1H NMR (DMSO-d6), ppm IR (KBr), cm
1
6 12.31 (br, 1H, NH), 7.69 (d, J¼ 8.0 Hz, 1H, Ar—H),
7.47 (t, J¼ 6.8 Hz, 1H, Ar—H), 7.29 (m, 2H, Ar—H), 2.42 (s, 3H, CH3)
3308 (NH), 1669 (C—O)
7 12.23 (br, 1H, NH), 7.58–7.05 (m, 3H, Ar—H), 2.39 (s, 3H, CH3), 2.37 (s, 3H, CH3) 3312 (NH), 1667 (C—O)
8 12.73 (br, 1H, NH), 8.41–7.37 (m, 3H, Ar—H), 2.44 (s, 3H, CH3) 3323 (NH), 1682 (C—O),
1539 (C—NO2), 1343 (C—NO2)
9 12.23 (br, 1H, NH), 7.25–7.71 (m, 2H, Ar—H), 2.40 (s, 3H, CH3) 3152 (NH), 1670 (C—O)
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monochromator. The generator power was set to 40 kV and
25mA. External calibration to convert the measured 4096
channels into 2u degrees was carried out with the Na2Ca3Al2F14
cubic phase mixed with silver behenate as external standard. The
peak positions were determined after pseudo-Voigt fitting by
using DIFFRACTINEL software.
Crystal structure determination from powder data
methodology
Peak positions were determined manually using the Peak picking
option of the PCmodelling platformMaterials Studio.[19] Potential
solutions of cell parameters and space groups were obtained
using the X-Cell[20] algorithm available in the Powder Indexing
module of Materials Studio. The cell parameters and space group
that best reproduced the experimental diffraction patterns were
chosen and refined using a Pawley profile-fitting procedure[21]
over a 2u range from 3.58 to 608. Pawley refinement was used to
provide refined cell parameters, the peak profile parameters
(profile function, FWHM and asymmetry), the background and
the zero shift. All the parameters used are consigned in Table 3.
Structure solution was attempted afterwards. First, the mole-
cule was drawn in a 3D worksheet and it wasminimised in energy
by geometry optimisation using the COMPASS force field[22] to
obtain relevant distances, angles and torsions for its various
bonds. Structure solution was attempted by direct-space
methods following a Monte-Carlo simulated annealing approach
and full profile comparison as implemented in Powder Solve.[23]
For 8, the minimised molecule shape was not correct, the
heterocyclic ring was flattened with the two nitrogen atoms
closer than those of the three other compounds. Therefore, the
molecule was drawn by adding the nitro group at themolecule of
compound 6. Considering the Cambridge Structural Database
CSD of the CCDC and literature data,[24–26] bond lengths and
torsion angles of the nitro group were set at 1.466 A˚, 1.220 A˚,
123.48 and 118.38, respectively, for C—N, N—O, O—N—O and
C—N—O (so, the four atoms are coplanar). The drawn molecule
was then set as a rigid body, but with the C2—C1—N13—O14
torsion angle involving the nitro group allowed to adjust freely
and it is placed inside the unit cell previously determined,
together with its homologues related by the space group
symmetry. The total number of degrees of freedom is seven:
three translations, three rotations and the dihedral angle of the
Table 2. Crystal structures refinement information and crystallographic data for compounds 6, 7 and 9 from X-rays single crystal
analysis
Compound 6 7 9
Empirical formula C9H8N2O C10H10N2O C9H6Cl2 N2O
Formula weight 160.17 174.20 229.06
Temperature (K) 293(2) 293(2) 293(2)
Crystal system Monoclinic Orthorhombic Triclinic
Space group P21/c Pbca P1
Z 4 8 2
a (A˚) 4.050(2) 5.0654(3) 5.941(4)
b (A˚) 11.240(2) 16.0072(7) 8.350(2)
c (A˚) 16.975(5) 21.9719(10) 10.160(3)
a (8) 90 90 67.81(2)
b (8) 91.38(3) 90 75.54(3)
g (8) 90 90 87.45(3)
Volume (A˚3) 772.5(5) 1781.5(2) 451.2(3)
d (g cm3) 1.377 1.299 1.686
Crystal size mm 0.25 0.15 0.15 0.20 0.10 0.10 0.20 0.15 0.15
Rall 0.0527 0.0705 0.0635
m (Cu-Ka) (mm
1) 0.758 0.699 6.181
2umax (8) 129.8 140.1 129.8
No. reflections used 1285 1645 1502
No. of parameters 111 121 129
Goodness of fit on F2 1.008 1.008 1.035
Final R
indices [I> 2s(I)]
R1¼ 0.0500,
wR2¼ 0.1316
R1¼ 0.0684,
wR2¼ 0.1831
R1¼ 0.0530,
wR2¼ 0.1566
Max. and min.
transmission
0.8948
and 0.8331
0.9334
and 0.8729
0.4575
and 0.3712
F(000) 336 736 232
(D/r) max (A˚3) 0.195 0.301 0.313
(D/r) min (A˚3) 0.223 0.175 0.243
CCDC deposition number 785053 785054 785055
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nitro group. Following the global optimisation algorithm, trial
structures are continuously generated by modifying the seven
degrees of freedom to find the trial structure that yields the
best agreement between calculated and experimental powder
patterns.
The following Rietveld procedure included refinement of the
translation, rotation and dihedral angle of the molecule, the
isotropic temperature factors, and the preferred orientations, also
with the parameters previously refined in the Pawley procedure.
Preferred-orientation corrections of the powder sample were
initially searched within the Powder Solve module by the
March–Dollase function[27] and the Rietveld–Toraya function[28,29]
for the final Rietveld refinement.
The experimental collected and the final calculated profiles for
8 are shown in Fig. 2 together with the difference plot between
them. Calculated and experimental profiles are in a good
agreement as shown by the difference plot (black curve) and the
reliability parameters (Table 3).
RESULTS AND DISCUSSION
The crystallographic data and structural parameters of refine-
ment at room temperature for 6, 7 and 9 are given in Table 2 and
in Table 3 for 8. They crystallise in three different systems.
Compound 6 is monoclinic, 7 orthorhombic as compound 1[13,14]
but with different space group. Compounds 8 and 9 are triclinic.
The ORTEP representations (with the ellipsoids drawn at the
50% probability level and including the atomic numbering) of
theses structures are shown in Fig. 3a, b, c, d for 6, 7, 9 and 8,
respectively. The molecules of these compounds are very similar
and intra-molecular bonds are comparable to those of.[13]
Relevant bond distances are summarised in Table 4. The carbon
ring is aromatic (mean C—C bond distance is 1.39 A˚). The
heterocyclic and benzene rings are planar, the dihedral angle
between the planes are small, 1.48, 0.58, 2.08 and 1.68[13] for 6, 7, 9
and 1, respectively. The C8—O11 double bonds vary between
1.228 and 1.239 A˚. For 8, the refined values of torsion angles
involving the nitro group are given in Table 5, they indicate that
the nitro group is slightly out of the heterocyclic ring plane.
Projections of the structures are shown in Figs. 4, 5, 6 and 7 for
6, 7, 8 and 9, respectively. The shortest donor –H   acceptor
distances are represented with blue dashed lines. Despite the
similarities of the molecule shapes, their packing in the crystal is
diverse as they crystallise in three distinct space groups. In the
orthorhombic structure of 7 (Fig. 5), molecules form a zigzag
along b direction with an angle of 838 between the molecules.
Though in the monoclinic structure of 6 (Fig. 4), the angles
between molecules are smaller, 178 and 258, respectively, for the
Table 3. Results from the Rietveld refinement for compound
8
Parameter Value
Empirical formula C9H7N3O3
Formula weight 205.18
Temperature (K) 293
Crystal system Triclinic
Space group P1
Z 2
Lattice parameters
a (A˚) 11.226 (2)
b (A˚) 11.168 (1)
c (A˚) 3.931(1)
a (8) 97.64 (1)
b (8) 95.38 (1)
g (8) 101.56 (1)
Volume (A˚3) 474.9(6)
d (g cm3) 1.435
2u-angular range 5.0–65.0
2u-shift (zero correction) 0.01797 0.00098
Asymmetry parameters (Finger–Cox–Jephcoat function)
2u limit 17.000
H/L 0.02015 0.00015
S/L 0.02032 0.00015
Reliability parameters
Rwp 6.44%
Rp 4.46%
Peak shape parameters
u 0.03012 0.02508
v 0.04822 0.00882
w 0.00314 0.00068
Overall isotropic temperature
factor, U/A˚2
0.05932 0.00227
Preferred orientation (Rietveld–Toraya function)
a* 0.05932 0.00227
b* 0.20997 0.04292
c* 0.46389 0.02376
G1 0.15864 0.05758
G2 0.00000
CCDC deposition number 785056
Rwp ¼
P
i
wi cY
sim 2uið Þ Iexp 2uið Þ þ Yback 2uið Þ
 2 
=
P
i
wi I
exp 2uið Þj j2
1=2
.
Rp ¼
P
i
cYsim 2uið Þ Iexp 2uið Þ þ Yback 2uið Þ
  =P
i
Iexp 2uið Þj j.
Figure 2. Experimental (red circles) and calculated (blue line) diffraction
patterns along with the difference profile (black line) of 3 methyl 7
nitro 2(1H) quinoxalinone (compound 8) at 295K. Inset corresponds to
the scale for the data with 2u> 358
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2-fold screw axis and by the glide plane symmetry related
molecules. Compounds 8 and 9 have the same triclinic space
group but molecules are stacked differently. For 8 (Fig. 6), short
contact bonds involve the C12  H12A atoms of the methyl
substituent and the double bonded nitrogen N10 of the ring.
There are edge-to-edge overlaps of the benzene rings
between adjacent neighbouring molecules related by x, y,
z 1 and x, y, zþ 1 symmetry transformations. The C3C5
and C2C6 inter-molecular distance is 3.37 A˚. For 9 (Fig. 7), the
molecules are stacked by two hydrogen bonds involving N7—H7
and O11. Compounds 7 and 8 exhibit the same type of
hydrogen bonds as 9. The characteristic distances and angles
relative to the hydrogen bonds and short contacts are
summarised in Table 6. Compound 6 exihibits long hydrogen
bonds which can be related to the smallest size of R1 and R2
substituents.
Figure 3. ORTEP plots (with the ellipsoids drawn at the 50% probability level): (a) 3 methyl 2(1H) quinoxalinone (compound 6), (b)
3,7 dimethyl 2(1H) quinoxalinone (compound 7), (c) 3 methyl 6,7 dichloro 2(1H) quinoxalinone (compound 9) and (d) 3 methyl 7 nitro 2(1H) quinox
alinone (compound 8)
Table 4. Intramolecular bond distances in A˚: (a) Common
bonds (common distances in compound 8 have been con-
sidered as identical to those of compound 6), (b) Other bonds
Compounds
Bonds 6 7 9
(a)
N7—C4 1.380 1.377 1.362
N7—C8 1.345 1.354 1.346
N10—C3 1.387 1.384 1.391
N10—C9 1.291 1.288 1.286
C1—C2 1.365 1.375 1.378
C1—C6 1.401 1.402 1.402
C2—C3 1.398 1.396 1.398
C3—C4 1.400 1.401 1.424
C4—C5 1.393 1.395 1.379
C5—C6 1.368 1.373 1.369
C8—C9 1.482 1.490 1.497
C9—C12 1.485 1.453 1.486
O11—C8 1.239 1.232 1.228
Compounds Bond Distance
(b)
7 C6—C16 1.492
9 Cl13—C1 1.736
Cl16—C6 1.728
Table 5. Torsion angles involving the nitro group in com-
pound 8
Torsion Angle (8)
C6—C1—N13—O14 174.51
C6—C1—N13—O15 5.30
C2—C1—N13—O14 4.23
C2—C1—N13—O15 175.96
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Figure 4. Monoclinic structure of 3 methyl 2(1H) quinoxalinone (compound 6). Blue dotted lines indicate the hydrogen bonds. (a) (b, c) plane and (b) (a,
c) plane
Figure 5. Orthorhombic crystal structure of 3,7 dimethyl 2(1H) quinoxalinone (compound 7). (a) (b, c) plane and (b) (a, b) plane
Figure 6. Triclinic structure of 3 methyl 6,7 dichloro 2(1H) quinoxalinone (compound 9). (a) (b, c) plane and (b) (a, c) plane
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CONCLUSION
3-Methyl-2 (1H)-quinoxalinone and three derivatives (3,7-
dimethyl-2 (1H)-quinoxalinone, 3- methyl-6,7- dichloro- 2( 1H)-
quinoxalinone and 3- methyl-7-nitro-2(1H)-quinoxalinone) have
been synthesised and analysed by 1H NMR and IR spectral
spectroscopies.
The crystal structures have been determined at room
temperature from X-ray single crystal diffraction for three of
them and from powder diffraction for the nitro derivative. This
last structure was determined by the combination of direct space
Monte-Carlo simulated annealing methods and Rietveld refine-
ment combined with force-field-energy minimisation.
The shape of the molecules only differ by the presence
of different R1 and R2 substituents, the common intermolecular
distances are very similar. The benzene and the heterocyclic
rings are planar and the inter-ring dihedral angles are small
(28).
Crystal structures in terms of crystal packing are very different.
3-Methyl-2(1H)-quinoxalinone crystallises in the monoclinic
system, 3,7-dimethyl-2(1H)-quinoxalinone in the orthorhombic
system and the two others compounds in the triclinic system. For
compounds 6, 7 and 9, the molecules are united into
centro-symmetric dimers via N—H  O hydrogen bonds invol-
ving the atoms of the heterocyclic ring. For the nitro derivative
C—H  N short contact bonds are established between the
double bonded nitrogen of the ring and the carbons of the
methyl.
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